Facebook tracking pixelHemochromatosis - AI-Powered ICD-10 Documentation
E83.110
ICD-10-CM
Hemochromatosis

Find essential information on hemochromatosis diagnosis, including clinical documentation tips, ICD-10-CM coding (E83.1), HFE gene testing, iron overload symptoms, transferrin saturation, serum ferritin levels, and treatment options like phlebotomy. Learn about hereditary hemochromatosis, genetic testing, and best practices for healthcare professionals managing this iron disorder. This resource provides valuable insights for accurate medical coding and comprehensive patient care related to hemochromatosis.

Also known as

Iron Overload
Hereditary Hemochromatosis
Secondary Hemochromatosis

Diagnosis Snapshot

Key Facts
  • Definition : Iron overload disorder causing excess absorption from food.
  • Clinical Signs : Fatigue, joint pain, abdominal pain, skin darkening, liver disease.
  • Common Settings : Primary care, gastroenterology, hepatology clinics.

Related ICD-10 Code Ranges

Complete code families applicable to AAPC E83.110 Coding
E83.1

Hemochromatosis

Disorder of iron metabolism causing excess iron absorption.

E83.0

Hereditary hemochromatosis

Genetically inherited iron overload disorder.

E83.8

Other specified iron overload

Iron overload not classified elsewhere, including secondary hemochromatosis.

K70-K77

Diseases of liver

Liver conditions that can be associated with or caused by iron overload, such as cirrhosis.

Code-Specific Guidance

Decision Tree for

Follow this step-by-step guide to choose the correct ICD-10 code.

Is the hemochromatosis hereditary/primary?

  • Yes

    Is it due to HFE gene?

  • No

    Is it secondary to another condition?

Code Comparison

Related Codes Comparison

When to use each related code

Description
Iron overload disorder
Secondary iron overload
Juvenile hemochromatosis

Documentation Best Practices

Documentation Checklist
  • Hemochromatosis diagnosis documented
  • Iron overload symptoms/signs specified
  • Transferrin saturation and ferritin levels
  • Genetic testing results (e.g., HFE gene)
  • Liver function tests documented

Coding and Audit Risks

Common Risks
  • Unspecified Type Risk

    Coding hemochromatosis without specifying the type (primary/secondary/hereditary) leads to inaccurate reporting and potential claim denials. Use specific ICD-10-CM codes like E83.11.

  • Manifestation Miscoding

    Incorrectly coding manifestations of hemochromatosis (diabetes, cirrhosis) as the primary diagnosis instead of the underlying hemochromatosis. Ensure E83.1 codes are primary when applicable.

  • Overcoding Iron Overload

    Coding both hemochromatosis and iron overload (E83.1 and E70.0) when only hemochromatosis is diagnosed. Iron overload is a feature of the condition, not a separate diagnosis.

Mitigation Tips

Best Practices
  • Code H632 for hemochromatosis. Verify diagnosis for CDI.
  • Document iron overload details, genetic test results (ICD-10-CM).
  • HCC risk adjustment: capture secondary diagnoses, adhere to coding guidelines.
  • Phlebotomy frequency, ferritin levels must be documented for compliance.
  • Genetic counseling documentation improves patient care, ensures coding accuracy.

Clinical Decision Support

Checklist
  • Elevated transferrin saturation: Document value and date.
  • Elevated serum ferritin: Document value, date, and exclude other causes.
  • HFE gene testing: Document test type and results (e.g., C282Y, H63D).
  • Iron overload symptoms: Document specific symptoms (e.g., fatigue, joint pain).

Reimbursement and Quality Metrics

Impact Summary
  • Hemochromatosis reimbursement hinges on accurate ICD-10-CM coding (E83.1) and appropriate documentation of iron overload. Impacts: optimized coding maximizes payer reimbursements; HCC risk adjustment accuracy.
  • Quality metrics for hemochromatosis focus on early diagnosis, treatment (phlebotomy, chelation), and monitoring of serum ferritin and transferrin saturation. Impacts: improved patient outcomes; reduced long-term complications (cirrhosis, diabetes).
  • Regular monitoring and data reporting of hemochromatosis cases are crucial. Impacts: data-driven insights improve care protocols; informs public health initiatives for early detection programs.
  • Effective hemochromatosis management necessitates multidisciplinary collaboration (hepatologists, primary care). Impacts: enhanced care coordination; minimized hospital readmissions linked to hemochromatosis-related complications.

Streamline Your Medical Coding

Let S10.AI help you select the most accurate ICD-10 codes. Our AI-powered assistant ensures compliance and reduces coding errors.

Quick Tips

Practical Coding Tips
  • Code primary hemochromatosis E83.1
  • Document iron overload specifics
  • Specify hereditary vs secondary
  • Use additional codes for organ damage
  • Query physician if diagnosis unclear

Documentation Templates

Patient presents with symptoms suggestive of hemochromatosis, including fatigue, joint pain, abdominal pain, and skin darkening.  Relevant medical history includes elevated liver enzymes (AST, ALT), elevated serum iron, elevated transferrin saturation, and elevated ferritin.  Family history of hemochromatosis was also noted.  Physical examination revealed hepatomegaly and skin hyperpigmentation.  Genetic testing for HFE gene mutations (C282Y and H63D) was ordered to confirm the diagnosis of hereditary hemochromatosis.  Differential diagnosis considered iron overload, liver disease, and other metabolic disorders.  Initial diagnosis is consistent with hemochromatosis based on clinical presentation, laboratory findings, and risk factors.  Treatment plan includes therapeutic phlebotomy to reduce iron overload, monitoring of iron levels (serum iron, ferritin, transferrin saturation), and management of complications such as liver disease, diabetes, and cardiomyopathy.  Patient education provided on hemochromatosis, its management, and the importance of adherence to the treatment plan.  ICD-10 code E83.1 (Hereditary hemochromatosis) is assigned.  Follow-up appointment scheduled to monitor treatment response and assess for potential complications.  Patient advised to maintain a low-iron diet and avoid iron supplements.  Further evaluation and management may be required based on the patient's response to therapy and the development of any complications.